Effects of Different Doses of Dexmedetomidine Combined with Dezocine on Postoperative Pain and Cognitive Function in Patients Undergoing Thoracoscopic Lung Cancer Radical Surgery
YANG Yu, LIU Min, ZHU Qinqin
Department of Anesthesiology, Shanghai Huangpu District Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai 200436
Abstract:【Objective】 To investigate the effects of different doses of dexmedetomidine (Dex) combined with dezocine on postoperative pain and cognitive function in patients undergoing thoracoscopic lung cancer radical surgery. 【Methods】A total of 122 lung cancer patients were randomly divided into the observation group and the control group, with 61 cases in each group. The observation group received high-dose (1.2 μg/kg) Dex combined with dezocine anesthesia, while the control group received low-dose (0.8 μg/kg) Dex combined with dezocine anesthesia. The hemodynamic levels at different anesthesia time points, postoperative pain responses, levels of inflammatory factors [tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)] after surgery, postoperative cognitive function, and incidence of adverse reactions were compared between the two groups. 【Results】 At pre-anesthesia (T0), immediately after endotracheal extubation (T1), and postoperatively (T2), there were no statistically significant differences in oxygen saturation (SpO2) levels between the two groups (P>0.05). At T1,T2, both heart rate (HR) and mean arterial pressure (MAP) levels in both groups were lower than at T0 (P<0.05), and the observation group was lower than the control group (P<0.05). The pain scores at 6 hours and 12 hours postoperatively were lower than at 1 hour postoperatively in both groups (P<0.05), and the pain scores at 12 hours postoperatively were lower than at 6 hours postoperatively (P<0.05). Additionally, the observation group had lower pain scores at 1 hour, 6 hours, and 12 hours postoperatively compared to the control group (P<0.05). Postoperatively, TNF-α and IL-6 levels in both groups were lower than preoperatively (P<0.05), and the observation group was lower than the control group (P<0.05). There were no statistically significant differences in cognitive function scores between the two groups at 72 hours postoperatively compared to preoperatively (P>0.05). Cognitive function levels in both groups were higher at 72 hours postoperatively compared to preoperatively (P<0.05). 【Conclusion】 High-dose Dex combined with dezocine used in anesthesia for thoracoscopic lung cancer radical surgery is more advantageous in reducing postoperative pain levels and inflammation compared to low-dose Dex, minimizing cognitive function impairment with good safety.
杨煜, 刘岷, 朱芩芩. 不同剂量右美托咪定联合地佐辛对胸腔镜肺癌根治术患者术后疼痛和认知功能的影响[J]. 医学临床研究, 2024, 41(12): 1833-1835.
YANG Yu, LIU Min, ZHU Qinqin. Effects of Different Doses of Dexmedetomidine Combined with Dezocine on Postoperative Pain and Cognitive Function in Patients Undergoing Thoracoscopic Lung Cancer Radical Surgery. JOURNAL OF CLINICAL RESEARCH, 2024, 41(12): 1833-1835.
[1] JANNU V. Effect of intraoperative dexmedetomidine on postoperative pain and pulmonary function following video-assisted thoracoscopic surgery[J].Anesth Essays Res,2020,14(1):68-71.
[2] 王乐,闻庆平,苗壮,等. 右美托咪定联合酮咯酸氨丁三醇对胸腔镜肺癌根治术术后患者疼痛及免疫功能的影响[J].中国医科大学学报,2019,48(9):794-800.
[3] 杨全全,刘政,雍文成,等. 右美托咪啶对老年胸腔镜肺癌根治术患者免疫功能、血流动力学及应激反应的影响[J].海南医学院学报,2019,25(20):1581-1584.
[4] 中华医学会,中华医学会肿瘤学分会,中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2019版)[J].中华肿瘤杂志,2020,42(4):257-287.
[5] GAWEDA B, BORYS M, BELINA B, et al. Postoperative pain treatment with erector spinae plane block and pectoralis nerve blocks in patients undergoing mitral/tricuspid valve repair:a randomized controlled trial[J].BMC Anesthesiol,2020,20(1):51.
[6] PARK J, CHOI H, JANG J W, et al. Validation of a new screening tool for dementia: the simple observation checklist for activities of daily living[J].J Clin Neurol,2021,17(1):106-112.
[7] HUYAN T, HU X J, PENG H R, et al. Perioperative dexmedetomidine reduces delirium in elderly patients after lung cancer surgery[J].Psychiatr Danub,2019,31(1):95-101.
[8] 袁琳,梁培,夏洪韬,等. 不同剂量右美托咪定复合舒芬太尼对肺癌根治术后患者炎性细胞因子和认知功能的影响[J].现代生物医学进展,2019,19(7):1357-1361.
[9] 吴婷婷,王国强. 地佐辛复合右美托咪定麻醉与老年肺癌患者术后心电图监测结果、血清MDA水平及T淋巴细胞亚群的关系[J].中国老年学杂志,2020,40(8):1643-1647.
[10] ZHOU Z G, LIU R, TAN H L, et al. The application of dexmedetomidine combined with dezocine in thoracoscopic radical resection of lung cancer and its effect on awakening quality of patients[J].Eur Rev Med Pharmacol Sci,2019,23(17):7694-7702.
[11] 李国利,高晓茹,王暐,等. 右美托咪定复合舒芬太尼对肺癌患者术后镇痛效果及细胞免疫功能的影响[J].天津医药,2020,48(5):396-401.
[12] 武长君,钱鹏. 右美托咪定联合盐酸艾司洛尔对肺癌根治术病人肺保护作用及其对Toll样受体4/核因子-κB信号通路的影响[J].安徽医药,2021,25(6):1246-1250.
[13] 邱郁薇,赵政政,吴镜湘,等. 复合右美托咪定或硬膜外阻滞对全身麻醉下胸腔镜肺癌手术患者围手术期炎性因子的影响[J].国际麻醉学与复苏杂志,2020,41(1):43-47.
[14] 郭盟迪,张璇,寇立华,等. 右美托咪定对胸腔镜下肺癌根治术后患者血清炎症因子水平与肺部感染发生率的影响[J].广西医学,2021,43(5):534-536.